Ligand raises EPS guidance floor, closes XOMA Royalty deal, reports pipeline progressAug 6Quarterly updateLigand Pharmaceuticals Inc
Mirum raises 2026 sales guidance, volixibat gets FDA breakthrough status for PSCAug 5Quarterly updateMirum Pharmaceuticals, Inc.volixibat
Sign inSign in